Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BYBiomedicines

Culture Dimensionality Shapes Drug Sensitivity to Kinase Inhibitor Combinations with Epigenetic or Metabolic Inhibition in a Hepatocellular Carcinoma Model

  • Claudia Kunst1
  • Tobias Schilling2
  • Cedric Arling1
  • Manuela Peisl-Gunckel1
  • Sophie Schlosser-Hupf1
  • Karsten Gülow1
  • Martina Müller1
  1. 1Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, Immunology and Infectious Diseases, , 93053 Regensburg, Germany; (C.A.); (M.P.-G.); (S.S.-H.); (K.G.); (M.M.)
  2. 2Department of Emergency and Intensive Care Medicine, , 70174 Stuttgart, Germany;
Read full textPDFCite

Related

  1. Integrative Multi-Database Bioinformatics Characterization of FANCE in Hepatocellular Carcinoma: Prognostic, Epigenetic, Immune, and ncRNA Associations
    Yeong Chae Kim, Kyu-Shik Lee, Hye-Ran Kim +1
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction].
    Cancer management and researchPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  3. Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling
    Sijing Chen, Yunyang Zhao, Yunqi Pan +13
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Palmatine Induces TNNT1 Ubiquitination and Degradation to Potentiate Ferroptosis Sensitivity in Hepatocellular Carcinoma
    Xiaokang Wang, Fanci Xie, Chunhua Wang +4
    Journal of Clinical and Translational HepatologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Construction of a five-gene prognostic model involving T cell exhaustion and metabolic reprogramming for predicting hepatocellular carcinoma risk using LASSO: insights into immune infiltration and drug sensitivity
    Shaogang Wang, Ying Chen, Yu Mao +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref

Cite

BibTeXRIS
BibTeX
@article{kunst2026culture,
  title = {{Culture Dimensionality Shapes Drug Sensitivity to Kinase Inhibitor Combinations with Epigenetic or Metabolic Inhibition in a Hepatocellular Carcinoma Model}},
  author = {Claudia Kunst and Tobias Schilling and Cedric Arling and Manuela Peisl-Gunckel and Sophie Schlosser-Hupf and Karsten Gülow and Martina Müller},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13701745},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Culture Dimensionality Shapes Drug Sensitivity to Kinase Inhibitor Combinations with Epigenetic or Metabolic Inhibition in a Hepatocellular Carcinoma Model
AU  - Claudia Kunst
AU  - Tobias Schilling
AU  - Cedric Arling
AU  - Manuela Peisl-Gunckel
AU  - Sophie Schlosser-Hupf
AU  - Karsten Gülow
AU  - Martina Müller
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701745
SN  - 2227-9059
ER  -